ID
22817
Description
Study ID: 100310 Clinical Study ID: RRL100310 Study Title: A 12-week, double-blind, placebo-controlled, parallel group study to assess the efficacy and safety of intermittent dosing of ropinirole in patients with Restless Legs Syndrome (RLS) Part 15: Visit 3 (Week 5) RLS Episode 3 Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00225862 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication: Restless Legs Syndrome More details on: https://clinicaltrials.gov/ct2/show/NCT00225862
Link
https://clinicaltrials.gov/ct2/show/NCT00225862
Keywords
Versions (2)
- 6/8/17 6/8/17 -
- 6/12/17 6/12/17 -
Uploaded on
June 12, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Intermittent Ropinirole in Restless Legs Syndrome (RLS) NCT00225862 - Part 15: Visit 3 (Week 5) RLS Episode 3
Intermittent Ropinirole in Restless Legs Syndrome (RLS) NCT00225862 - Part 15: Visit 3 (Week 5) RLS Episode 3
Description
PRN Subject Diary
Alias
- UMLS CUI-1
- C3890583
- UMLS CUI-2
- C0035258
Description
Date
Data type
datetime
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0040223
- UMLS CUI [1,3]
- C0035258
- UMLS CUI [1,4]
- C1457887
Description
Severity of RLS episode
Data type
text
Alias
- UMLS CUI [1,1]
- C0439793
- UMLS CUI [1,2]
- C0035258
- UMLS CUI [1,3]
- C1457887
- UMLS CUI [2]
- C0013227
Description
Did your RLS symptoms disrupt your routine evening activity?
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0332453
- UMLS CUI [1,2]
- C0001288
- UMLS CUI [1,3]
- C0035258
Description
Severity two hours after medication
Data type
text
Alias
- UMLS CUI [1,1]
- C0439793
- UMLS CUI [1,2]
- C1457887
- UMLS CUI [1,3]
- C0035258
- UMLS CUI [2]
- C0013227
Description
Read the following and complete the questions when you wake up next morning.
Data type
text
Alias
- UMLS CUI [1,1]
- C1515926
- UMLS CUI [1,2]
- C1457887
- UMLS CUI [1,3]
- C0035258
- UMLS CUI [2]
- C0013227
Description
Sleep affected by RLS symptoms?
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0037313
- UMLS CUI [1,2]
- C0392760
- UMLS CUI [1,3]
- C0035258
Description
Specification of RLS symptoms affecting sleep
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0393760
- UMLS CUI [1,2]
- C0037317
- UMLS CUI [1,3]
- C0035258
Description
Study Medication
Alias
- UMLS CUI-1
- C0013227
- UMLS CUI-2
- C0304229
- UMLS CUI-3
- C0008976
- UMLS CUI-4
- C0035258
Similar models
Intermittent Ropinirole in Restless Legs Syndrome (RLS) NCT00225862 - Part 15: Visit 3 (Week 5) RLS Episode 3
C1955348 (UMLS CUI-2)
C0035258 (UMLS CUI-3)
C0040223 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C1457887 (UMLS CUI [1,4])
C0035258 (UMLS CUI [1,2])
C1457887 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2])
C0001288 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C1457887 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2])
C1457887 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2])
C0392760 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0037317 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0304229 (UMLS CUI-2)
C0008976 (UMLS CUI-3)
C0035258 (UMLS CUI-4)
C0013227 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
No comments